Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]
, 2011 Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar +21 more
core +1 more source
Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis [PDF]
Терапевтический архив, 2019 Aim. Сomparative studying of changes in the spectrum of bile acids in bile in patients with nonalcoholic fatty liver disease and cholelithiasis. Materials and methods.
Ya M Vakhrushev +3 more
doaj +1 more source
Nonalcoholic Fatty Liver Disease
New England Journal of Medicine, 2002 Nonalcoholic fatty liver disease (NAFLD) is present in up to one third of the general population and in the majority of patients with metabolic risk factors such as obesity and diabetes. Insulin resistance is a key pathogenic factor resulting in hepatic fat accumulation. Recent evidence demonstrates NAFLD in turn, exacerbates hepatic insulin resistance
Jeanne M, Clark +2 more
openaire +5 more sources
Nonalcoholic fatty liver disease [PDF]
Canadian Medical Association Journal, 2005 Nonalcoholic fatty liver disease is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and ...
Leon A, Adams +2 more
openaire +3 more sources
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments [PDF]
Clinical and Molecular Hepatology, 2023 Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis.
Sang Bong Ahn
doaj +1 more source
How big a problem is non-alcoholic fatty liver disease? [PDF]
, 2011 This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting ...
McPherson, Stuart +5 more
core +1 more source
Relevant issues in the diagnosis and treatment of nonalcoholic fatty liver disease
Медицинский совет, 2015 Nonalcoholic fatty liver disease is a chronic disease uniting steatosis, nonalcoholic steatohepatitis and cirrhosis. Nonalcoholic fatty liver disease is associated with obesity and is a component of metabolic syndrome, thus increasing cardiometabolic ...
E. A. Cherkashina
doaj +1 more source
ASSOCIATION OF ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS WITH NONALCOHOLIC FATTY LVER DISEASE
Pakistan Armed Forces Medical Journal, 2019 Objective: To study the association of anthropometric and biochemical parameters with nonalcoholic fatty liver disease (NAFLD) diagnosed on ultrasonography (USG). Study Design: Cross sectional analytical study.
Muhammad Usman Munir +3 more
doaj +4 more sources
Nonalcoholic Fatty Liver Disease in Children: a Modern View on the Diagnosis and Treatment (II Part)
Gastroenterologìa, 2015 In Part II methods of research and treatment of nonalcoholic fatty liver disease in children are highlighted, which are based on the evidence. Ultrasound examination of the liver is the most common method for diagnosis of nonalcoholic fatty liver disease
Y.M. Stepanov +3 more
doaj +1 more source
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. [PDF]
, 2011 AIMS: Non-alcoholic fatty liver disease (NAFLD) is a complex disease trait where genetic variations and environment interact to determine disease progression.
Patch, Julia +32 more
core +1 more source